Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-12-02
1998-10-06
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142328, 5142335, 5142377, 5142388, 5142392, 5142395, 514252, 514318, 514332, 514340, 514343, 514346, 514347, 514351, 514520, 514521, 514568, 514570, A61K 3119, A61K 3141
Patent
active
058176845
ABSTRACT:
This invention provides methods for the treatment or prevention of cerebral focal ischemia which comprises administering to a mammal in need thereof an effective amount of a compound having activity as a leukotriene B.sub.4 antagonist.
REFERENCES:
patent: 5462954 (1995-10-01), Baker et al.
Fleisch Jerome H.
Jackson William T.
Sawyer Jason S.
Boone David E.
Eli Lilly and Company
Palmberg Arleen
Schenkman Leonard
LandOfFree
Leukotriene antagonists for use in the treatment or inhibition o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Leukotriene antagonists for use in the treatment or inhibition o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leukotriene antagonists for use in the treatment or inhibition o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-77642